Fragile X syndrome

News and Video Search Results

News coverage

Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy

GlobeNewswire 30 Apr 2024

WAKIX^® (pitolisant) Net Revenue of $154.6 Million for First Quarter 2024; ~30% Growth Year-over-YearSupplemental New Drug..

Avance Clinical Showcases Clinical Excellence at World Orphan Drug Conference in Boston, April 23-25
ACN Newswire 19 Apr 2024
New technique sheds light on memory and learning
Science Daily 09 Apr 2024
The BWB Awards at Biotech Week Boston Return for a Celebratory Gala September 23rd, 2024
Accesswire 02 Apr 2024
Anavex Life Sciences Reports Fiscal 2024 First Quarter Financial Results and Provides Business Update
GlobeNewswire 07 Feb 2024

0 shares 1 views

You might like

Fragile X syndrome media coverage

Revolutionizing Care: NeuroQure's Groundbreaking Path to Treating Genetic Intellectual Disabilities

Upworthy 06 Nov 2023

IRVINE, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- NeuroQure has embarked on a transformative journey aimed at revolutionizing the..

Prime Medicine Reports Third Quarter 2023 Financial Results and Provides Business Updates
GlobeNewswire 03 Nov 2023
Discovery reveals fragile X syndrome begins developing even before birth
Science Daily 10 Oct 2023
Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023
GlobeNewswire 29 Sep 2023
Zynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q11.2 Deletion Syndrome at The Society for the Study of Behavioural Phenotypes (SSBP) 25th International Research Symposium
GlobeNewswire 14 Sep 2023

Advertisement

More coverage

How Genetic Technologies Can Empower More People With Information

Accesswire 09 Aug 2023

*Originally published on Illumina News Center*

*NORTHAMPTON, MA / ACCESSWIRE / August 9, 2023 / *After earning a..

Finalists Unveiled for 2023 BWB Awards: Biotech Week Boston's Dazzling Gala on September 18th, 2023
Accesswire 02 Aug 2023
PureTech Awarded up to $11.4 Million from U.S. Department of Defense to Advance LYT-300 (Oral Allopregnanolone) for Fragile X-associated Tremor/Ataxia Syndrome
Business Wire 01 Aug 2023
Zynerba Pharmaceuticals Announces New Date for Reconvened Annual Meeting
GlobeNewswire 25 Jul 2023
Acadia Pharmaceuticals Acquires Ex-North American Rights to Trofinetide and Global Rights to Neuren’s NNZ-2591 in Rett Syndrome and Fragile X Syndrome
Business Wire 13 Jul 2023